RAPS members, I’m very excited to share the March issue of RF Quarterly with you. This issue of our members-only publication is a collation of articles on the EU Clinical Trials Regulation.
The articles examine the associated challenges and opportunities, accounts of early experiences and the lessons learned, strategic considerations, and practical approaches to the transparency stipulations related to the EU CTR
The EU Clinical Trials Regulation: Experiences from the first 18 months
Chris Bamford, PhD • Carolina Arias, BA
The emerging transparency paradigm for clinical trials in Europe
Sameer Sharma, MPharm • Christopher Price, MA • @Susan Bhatti, PhD •
@Srinivas Patchala, MBA • Robert Janiak, PhD • Lisette Vromans
The EU CTR: Opportunities, challenges, and lessons learned
Bettina Goldberg, MPharm • Esther Gil, MSc, BSc Pharmacy •
Celina González-Colaço, BSc Pharmacy • @Cristina Lupo, BSc Pharmacy
Strategic considerations and submission processes under the EU CTR
@Ana Sengupta, MBA, MS, RAC
If you’re interested in contributing a peer-reviewed article to Regulatory Focus, please email me at rmatthews@raps.org
------------------------------
Renee Matthews
Senior Editor, Regulatory Focus
RAPS
Rockville, MD
United States
------------------------------